BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 33591951)

  • 1. Association of D-dimer elevation with inflammation and organ dysfunction in ICU patients with COVID-19 in Wuhan, China: a retrospective observational study.
    Zhang W; Sang L; Shi J; Zhong M; Jiang L; Song B; Kang L; Zhang Y; Zhang D; Yu Y; Zheng X
    Aging (Albany NY); 2021 Feb; 13(4):4794-4810. PubMed ID: 33591951
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The inflammatory biomarkers profile of hospitalized patients with COVID-19 and its association with patient's outcome: A single centered study.
    Hachim IY; Hachim MY; Hannawi H; Naeem KB; Salah A; Hannawi S
    PLoS One; 2021; 16(12):e0260537. PubMed ID: 34855832
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study.
    Zhou F; Yu T; Du R; Fan G; Liu Y; Liu Z; Xiang J; Wang Y; Song B; Gu X; Guan L; Wei Y; Li H; Wu X; Xu J; Tu S; Zhang Y; Chen H; Cao B
    Lancet; 2020 Mar; 395(10229):1054-1062. PubMed ID: 32171076
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improvement in plasma D-dimer level in severe SARS-CoV-2 infection can be an indicator of fibrinolysis suppression: Case reports.
    Manzoor D; Bui C; Makhoul E; Luthringer D; Marchevsky A; Volod O
    Medicine (Baltimore); 2021 Apr; 100(15):e25255. PubMed ID: 33847623
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Relationship between D-dimer concentration and inflammatory factors or organ function in patients with coronavirus disease 2019].
    Xu Y; Qian Y; Gu Q; Tang J
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2020 May; 32(5):559-563. PubMed ID: 32576347
    [TBL] [Abstract][Full Text] [Related]  

  • 6. D-dimer levels on admission to predict in-hospital mortality in patients with Covid-19.
    Zhang L; Yan X; Fan Q; Liu H; Liu X; Liu Z; Zhang Z
    J Thromb Haemost; 2020 Jun; 18(6):1324-1329. PubMed ID: 32306492
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coagulopathy of hospitalised COVID-19: A Pragmatic Randomised Controlled Trial of Therapeutic Anticoagulation versus Standard Care as a Rapid Response to the COVID-19 Pandemic (RAPID COVID COAG - RAPID Trial): A structured summary of a study protocol for a randomised controlled trial.
    Sholzberg M; Tang GH; Negri E; Rahhal H; Kreuziger LB; Pompilio CE; James P; Fralick M; AlHamzah M; Alomran F; Tseng E; Lim G; Lillicrap D; Carrier M; Áinle FN; Beckett A; da Costa BR; Thorpe K; Middeldorp S; Lee A; Cushman M; Jüni P
    Trials; 2021 Mar; 22(1):202. PubMed ID: 33691765
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship of D-dimer with severity and mortality in SARS-CoV-2 patients : A meta-analysis.
    Nugroho J; Wardhana A; Maghfirah I; Mulia EPB; Rachmi DA; A'yun MQ; Septianda I
    Int J Lab Hematol; 2021 Feb; 43(1):110-115. PubMed ID: 32931146
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Association of D-dimer, inflammatory markers, cytokines abnormality, and disease severity in COVID-19 severe/critical patients in Wuhan].
    Zhang J; Gao XL; Li DJ; Jiang Y; Liu Y; Pang L; Xu D; Yang LH
    Zhonghua Xue Ye Xue Za Zhi; 2020 Nov; 41(11):927-931. PubMed ID: 33333696
    [No Abstract]   [Full Text] [Related]  

  • 10. Dyslipidemia Is Related to Mortality in Critical Patients With Coronavirus Disease 2019: A Retrospective Study.
    Yue J; Xu H; Zhou Y; Liu W; Han X; Mao Q; Li S; Tam LS; Ma J; Liu W
    Front Endocrinol (Lausanne); 2021; 12():611526. PubMed ID: 34248834
    [TBL] [Abstract][Full Text] [Related]  

  • 11. d-dimer and Death in Critically Ill Patients With Coronavirus Disease 2019.
    Short SAP; Gupta S; Brenner SK; Hayek SS; Srivastava A; Shaefi S; Singh H; Wu B; Bagchi A; Al-Samkari H; Dy R; Wilkinson K; Zakai NA; Leaf DE;
    Crit Care Med; 2021 May; 49(5):e500-e511. PubMed ID: 33591017
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characteristics and outcomes of critically ill patients with covid-19 in Sakarya, Turkey: a single centre cohort study.
    Kocayiğit H; Özmen Süner K; Tomak Y; Demir G; Kocayiğit İ; Yaylacı S; Aydemir Y; Köroğlu M; Karabay O; Öztürk MH; Erdem AF
    Turk J Med Sci; 2021 Apr; 51(2):440-447. PubMed ID: 33185365
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic value of a new quantitative D-dimer test in critically ill patients 24 and 48 h following admission to the intensive care unit.
    Shitrit D; Izbicki G; Shitrit AB; Kramer MR; Rudensky B; Sulkes J; Hersch M
    Blood Coagul Fibrinolysis; 2004 Jan; 15(1):15-9. PubMed ID: 15166938
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coagulation dysfunction in ICU patients with coronavirus disease 2019 in Wuhan, China: a retrospective observational study of 75 fatal cases.
    Shi J; Zhang W; Sang L; Qu Z; Zhong M; Jiang L; Song B; Kang L; Zhang Y; Wang X; Zhang D; Zheng X
    Aging (Albany NY); 2020 Dec; 13(2):1591-1607. PubMed ID: 33318314
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DVT incidence and risk factors in critically ill patients with COVID-19.
    Chen S; Zhang D; Zheng T; Yu Y; Jiang J
    J Thromb Thrombolysis; 2021 Jan; 51(1):33-39. PubMed ID: 32607652
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inflammation/coagulopathy/fibrinolysis: Dynamic indicators of COVID-19 progression in patients with moderate COVID-19 in Wenzhou, China.
    An H; Zhang J; Zhou T; Li T; Li S; Huang C; Chen C; Ying B; Xu Z; Jin S; Li X; Li M
    Clin Immunol; 2021 Nov; 232():108852. PubMed ID: 34520860
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidemiological, clinical, and laboratory findings for patients of different age groups with confirmed coronavirus disease 2019 (COVID-19) in a hospital in Saudi Arabia.
    Ibrahim ME; Al-Aklobi OS; Abomughaid MM; Al-Ghamdi MA
    PLoS One; 2021; 16(4):e0250955. PubMed ID: 33914805
    [TBL] [Abstract][Full Text] [Related]  

  • 18. What Is the Impact of Baseline Inflammatory and Hemostatic Indicators with the Risk of Mortality in Severe Inpatients with COVID-19: A Retrospective Study.
    Zhu H; Li Y; Su H; Yan C; Xin W; Ying K
    Clin Appl Thromb Hemost; 2024; 30():10760296241255959. PubMed ID: 38831596
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical characteristics and risk factors for symptomatic venous thromboembolism in hospitalized COVID-19 patients: A multicenter retrospective study.
    Li JY; Wang HF; Yin P; Li D; Wang DL; Peng P; Wang WH; Wang L; Yuan XW; Xie JY; Zhou F; Xiong N; Shao F; Wang CX; Tong X; Ye H; Wan WJ; Liu BD; Li WZ; Li Q; Tang LV; Hu Y; Lip GYH;
    J Thromb Haemost; 2021 Apr; 19(4):1038-1048. PubMed ID: 33534149
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The clinical implication of dynamic neutrophil to lymphocyte ratio and D-dimer in COVID-19: A retrospective study in Suzhou China.
    Fu J; Kong J; Wang W; Wu M; Yao L; Wang Z; Jin J; Wu D; Yu X
    Thromb Res; 2020 Aug; 192():3-8. PubMed ID: 32407937
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.